These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11026542)

  • 1. Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitors.
    Silvestri R; Artico M; De Martino G; Novellino E; Greco G; Lavecchia A; Massa S; Loi AG; Doratiotto S; La Colla P
    Bioorg Med Chem; 2000 Sep; 8(9):2305-9. PubMed ID: 11026542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
    Chimirri A; Grasso S; Monforte P; Rao A; Zappalà M; Monforte AM; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E
    Antivir Chem Chemother; 1999 Jul; 10(4):211-7. PubMed ID: 10480739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of novel 2H-pyran-2-one derivatives as potential HIV-1 reverse transcriptase inhibitors.
    Defant A; Mancini I; Tomazzolli R; Balzarini J
    Arch Pharm (Weinheim); 2015 Jan; 348(1):23-33. PubMed ID: 25523431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biaryl acids: novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2.
    Milton J; Slater MJ; Bird AJ; Spinks D; Scott G; Price CE; Downing S; Green DV; Madar S; Bethell R; Stammers DK
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2623-8. PubMed ID: 9873592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
    Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies.
    Silvestri R; De Martino G; La Regina G; Artico M; Massa S; Vargiu L; Mura M; Loi AG; Marceddu T; La Colla P
    J Med Chem; 2003 Jun; 46(12):2482-93. PubMed ID: 12773052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV-1 activity of pyrryl aryl sulfone (PAS) derivatives: synthesis and SAR studies of novel esters and amides at the position 2 of the pyrrole nucleus.
    Silvestri R; Artico M; La Regina G; De Martino G; La Colla M; Loddo R; La Colla P
    Farmaco; 2004 Mar; 59(3):201-10. PubMed ID: 14987983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro anti-HIV activity of certain 2-(1H-benzimidazol-2-ylamino)pyrimidin-4(3H)-ones and related derivatives.
    Badawey el-S ; Kappe T
    Arch Pharm (Weinheim); 1997 Mar; 330(3):59-62. PubMed ID: 9167448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
    Artico M; Silvestri R; Massa S; Loi AG; Corrias S; Piras G; La Colla P
    J Med Chem; 1996 Jan; 39(2):522-30. PubMed ID: 8558522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and biological evaluation of novel pyrrolyl aryl sulfones: HIV-1 non-nucleoside reverse transcriptase inhibitors active at nanomolar concentrations.
    Artico M; Silvestri R; Pagnozzi E; Bruno B; Novellino E; Greco G; Massa S; Ettorre A; Loi AG; Scintu F; La Colla P
    J Med Chem; 2000 May; 43(9):1886-91. PubMed ID: 10794705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Famiglini V; La Regina G; Coluccia A; Pelliccia S; Brancale A; Maga G; Crespan E; Badia R; Riveira-Muñoz E; Esté JA; Ferretti R; Cirilli R; Zamperini C; Botta M; Schols D; Limongelli V; Agostino B; Novellino E; Silvestri R
    J Med Chem; 2014 Dec; 57(23):9945-57. PubMed ID: 25418038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase.
    Sun Y; Xu W; Fan N; Sun X; Ning X; Ma L; Liu J; Wang X
    Bioorg Med Chem; 2017 Feb; 25(3):1076-1084. PubMed ID: 28082070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Murugesan V; Makwana N; Suryawanshi R; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Katti SB
    Bioorg Med Chem; 2014 Jun; 22(12):3159-70. PubMed ID: 24794742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.
    Ragno R; Coluccia A; La Regina G; De Martino G; Piscitelli F; Lavecchia A; Novellino E; Bergamini A; Ciaprini C; Sinistro A; Maga G; Crespan E; Artico M; Silvestri R
    J Med Chem; 2006 Jun; 49(11):3172-84. PubMed ID: 16722636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide.
    La Regina G; Coluccia A; Brancale A; Piscitelli F; Gatti V; Maga G; Samuele A; Pannecouque C; Schols D; Balzarini J; Novellino E; Silvestri R
    J Med Chem; 2011 Mar; 54(6):1587-98. PubMed ID: 21366296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
    Qin BJ; Zhou T; Lu H; Jiang SB; Xie L
    Yao Xue Xue Bao; 2009 Nov; 44(11):1233-43. PubMed ID: 21355324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.